ZNF300 and myelodysplastic syndrome: To further investigate the value of ZNF300 methylation in clinical diagnosis and risk/treatment assessment, we expanded the clinical samples (70 MDS and 160 AML) to explore the clinical significance of ZNF300 methylation through a more rapid and inexpensive methodology—RQ-MSP.